Considering BCG vaccination to reduce the impact of COVID-19

In addition to its specific effect against tuberculosis, the BCG vaccine has beneficial nonspecific (off-target) effects on the immune system that protect against a wide range of other infections and are used routinely to treat bladder cancer.1,2 This has led to the suggestion that vaccination with...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 395; no. 10236; pp. 1545 - 1546
Main Authors:	Curtis, Nigel, Sparrow, Annie, Ghebreyesus, Tedros A, Netea, Mihai G
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 16.05.2020 Elsevier Limited
Subjects:	Bacillus Calmette-Guerin vaccine BCG BCG Vaccine Betacoronavirus Bladder Children Coronaviridae Coronavirus Infections Coronaviruses Correspondence COVID-19 Ecological effects Ecological studies Health care Humans Immune system Immunity, Heterologous Immunization Infant mortality Infections Mortality Neonates Pandemics Pneumonia, Viral Public health Randomized Controlled Trials as Topic Respiratory diseases Respiratory tract Respiratory tract diseases RNA viruses SARS-CoV-2 Sepsis Severe acute respiratory syndrome coronavirus 2 Tuberculosis Vaccination Vaccines Viral diseases Viruses Netherlands
ISSN:	0140-6736, 1474-547X, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!